Abstract
Patients with Down’s syndrome (DS) have an increased incidence of coxarthrosis which may become symptomatic with prolonged life expectancy. We present seven consecutive patients (nine hips) with DS who had primary total hip arthroplasty (THA). Average clinical and radiological follow-up was 9.9 ± 6.4 years (range 2–22.25). Harris hip scores (HHS) improved significantly (p < 0.01) from 41.1 (range 18.5–65) to 80.2 (range 67.5–91) at latest follow-up. Two patients required revision arthroplasty for stem loosening at 16 (osteolysis) and six years (trauma) following THA, respectively. Six of the THAs required a constrained liner. No dislocations or deep infections were encountered. We contend that THA is a reliable surgical intervention in patients with DS and may be performed in symptomatic patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Stoll C, Alembik Y, Dott B, Roth MP (1998) Study of Down syndrome in 238,942 consecutive births. Ann Genet 41:44–51
Kriss VM (1999) Down syndrome: imaging of multiorgan involvement. Clin Pediatr 38:441–449
Nance WE, Engel E (1967) Human cytogenetics: a brief review and presentation of new findings. J Bone Joint Surg Am 49:1436–1454
Shaw ED, Beals RK (1992) The hip joint in Down's syndrome. A study of its structure and associated disease. A study of its structure and associated disease. Clin Orthop Relat Res 278:101–107
Penrose LS (1949) The incidence of mongolism in the general population. J Ment Sci 95:685–688
Bittles AH, Glasson EJ (2004) Clinical, social, and ethical implications of changing life expectancy in Down syndrome. Dev Med Child Neurol 46:282–286
Friedman JM (2001) Radical disparities in median age at death of persons with Down syndrome. United States, 1968–1997. MMWR Morb Mortal Wkly Rep 50:463–465
Glasson EJ, Sullivan SG, Hussain R, Petterson BA, Montgomery PD, Bittles AH (2002) The changing survival profile of people with Down's syndrome: implications for genetic counselling. Clin Genet 62:390–393
Glasson EJ, Sullivan SG, Hussain R, Petterson BA, Montgomery PD, Bittles AH (2003) Comparative survival advantage of males with Down syndrome. Am J Hum Biol 15:192–195
Janicki MP, Dalton AJ, Henderson CM, Davidson PW (1999) Mortality and morbidity among older adults with intellectual disability: health services considerations. Disabil Rehabil 21:284–294
Kioschos M, Shaw ED, Beals RK (1999) Total hip arthroplasty in patients with Down's syndrome. J Bone Joint Surg Br 81:436–439
Skoff HD, Keggi K (1987) Total hip replacement in Down's syndrome. Orthopedics 10:485–489
Hartofilakidis G, Stamos K, Karachalios T, Ioannidis TT, Zacharakis N (1996) Congenital hip disease in adults. Classification of acetabular deficiencies and operative treatment with acetabuloplasty combined with total hip arthroplasty. J Bone Joint Surg Am 78:683–692
Massin P, Schmidt L, Engh CA (1989) Evaluation of cementless acetabular component migration. An experimental study. J Arthroplasty 4:245–251
DeLee JG, Charnley J (1976) Radiological demarcation of cemented sockets in total hip replacement. Clin Orthop Relat Res 121:20–32
Kim YH (2008) The results of a proximally-coated cementless femoral component in total hip replacement: a five- to 12-year follow-up. J Bone Joint Surg Br 90:299–305
Engh CA Jr, Culpepper WJ, Engh CA (1997) Long-term results of use of the anatomic medullary locking prosthesis in total hip arthroplasty. J Bone Joint Surg Am 79:177–184
Kim YH, Kim JS, Oh SH, Kim JM (2003) Comparison of porous-coated titanium femoral stems with and without hydroxyapatite coating. J Bone Joint Surg Am 85:1682–1688
Kellett CF, Boscainos PJ, Maury AC, Pressman A, Cayen B, Zalzal P, Backstein D, Gross A (2007) Proximal femoral allograft treatment of Vancouver type-B3 periprosthetic femoral fractures after total hip arthroplasty. Surgical technique. J Bone Joint Surg Am 89:68–79
Maury AC, Pressman A, Cayen B, Zalzal P, Backstein D, Gross A (2006) Proximal femoral allograft treatment of Vancouver type-B3 periprosthetic femoral fractures after total hip arthroplasty. J Bone Joint Surg Am 88:953–958
Hresko MT, McCarthy JC, Goldberg MJ (1993) Hip disease in adults with Down syndrome. J Bone Joint Surg Br 75:604–607
Gill CE, Taylor HM, Lin KT, Padaliya BB, Newman WJ, Abramovitch AI, Richardson CR, Charles PD (2006) Difficulty in securing treatment for degenerative hip disease in a patient with Down syndrome: the gap remains open. J Natl Med Assoc 98:93–96
Goodman S, Pressman A, Saastamoinen H, Gross A (2004) Modified sliding trochanteric osteotomy in revision total hip arthroplasty. J Arthroplasty 19:1039–1041
Gross AE, Goodman S (2004) The current role of structural grafts and cages in revision arthroplasty of the hip. Clin Orthop Relat Res 429:193–200
Acknowledgements
The authors would like to thank Matthew Macdonald at the Mount Sinai Orthopedic Department for his support in statistical analysis and data collection for our study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kosashvili, Y., Taylor, D., Backstein, D. et al. Total hip arthroplasty in patients with Down’s syndrome. International Orthopaedics (SICOT) 35, 661–666 (2011). https://doi.org/10.1007/s00264-010-1030-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-010-1030-8